🔎 Trials Near Me

Domov › Crohnova bolezen › North Carolina › Durham

Klinične študije za Crohnova bolezen v Durham, NC

12 študij za Crohnova bolezen išče udeležence na lokacijah v Durham in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

A Remotely Conducted Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically

Vključevanje udeležencevFaza 4
  • University of North Carolina at Chapel Hill, Chapel Hill · 10 mi stran
Starost 18 in več · Ženske · Posodobljeno 5. okt. 2026 · NCT07654751

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Vključevanje udeležencevFaza 3
  • University of North Carolina Medical Center ( Site 5034), Chapel Hill · 10 mi stran
Starost 16–80 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06430801

A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

Vključevanje udeležencevFaza 3
  • University of North Carolina at Chapel Hill, Chapel Hill · 10 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07499232

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

Vključevanje udeležencevFaza 2/3
  • University of North Carolina, Chapel Hill · 10 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07196722

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Vključevanje udeležencevFaza 3
  • Duke University Medical Center-Site Number: 8400093, Durham
  • UNC Hospitals, The University of North Carolina at Chapel Hill-Site Number: 8400074, Chapel Hill · 10 mi stran
Starost 16–80 · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT07184931

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Vključevanje udeležencevFaza 3
  • UNC Hospitals, The University of North Carolina at Chapel Hill-Site Number: 8400074, Chapel Hill · 10 mi stran
Starost 16–80 · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT07184944

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease

Vključevanje udeležencevFaza 3
  • University of North Carolina Hospital, Chapel Hill · 10 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 28. avg. 2026 · NCT07577843

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

Vključevanje udeležencevOpazovalna študija
  • University of North Carolina, Chapel Hill · 10 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 5. avg. 2026 · NCT07237516

Comparing Over the Counter Pain Medicines for Discomfort in Crohn's Disease (AVID-CD)

Vključevanje udeležencev
  • University of North Carolina at Chapel Hill, Chapel Hill · 10 mi stran
Starost 18–44 · Ženske · Posodobljeno 14. jul. 2026 · NCT07337902

Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease

Vključevanje udeležencevFaza 3
  • Univ NC Chapel Hill /ID# 262198, Chapel Hill · 10 mi stran
Starost 2–17 · Vsi spoli · Posodobljeno 24. jun. 2026 · NCT06332534

COMPARE - Pediatric Inflammatory Bowel Disease (PIBD)

Vključevanje udeležencevOpazovalna študija
  • Duke Health System, Durham
  • University of North Carolina at Chapel Hill, Chapel Hill · 10 mi stran
Starost 1–18 · Vsi spoli · Posodobljeno 17. apr. 2026 · NCT07198113

A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease

Vključevanje udeležencevFaza 2
  • Investigational Site Number: 8400003, Chapel Hill · 10 mi stran
Starost 18–75 · Vsi spoli · Posodobljeno 27. mar. 2026 · NCT06958536

Študije za Crohnova bolezen v drugih mestih

Druge študije v Durham

Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.